Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Epoprostenol sodium 0.5mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoprostenol sodium |
Inferred relationship |
Some |
|
Epoprostenol sodium 1.5mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoprostenol sodium |
Inferred relationship |
Some |
|
epoprostenol 1,5 mg pulver og solvent til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoprostenol sodium |
Inferred relationship |
Some |
|
epoprostenol 500 µg pulver og solvent til infusionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Epoprostenol sodium |
Inferred relationship |
Some |
|
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoprostenol sodium |
Inferred relationship |
Some |
1 |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoprostenol sodium |
Inferred relationship |
Some |
1 |
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoprostenol sodium |
Inferred relationship |
Some |
1 |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoprostenol sodium |
Inferred relationship |
Some |
1 |
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoprostenol sodium |
Inferred relationship |
Some |
1 |
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Epoprostenol sodium |
Inferred relationship |
Some |
1 |